Company: AOSL
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001387467-25-000066
Chunk: 10

Company: ALPHA & OMEGA SEMICONDUCTOR Ltd
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 1
Chunk 10
---

As of September 30, 2025, the Company owned approximately 18.9% equity interest in the JV Company, which, by definition, is a related party to the Company. The JV Company supplies 12-inch wafers and provides assembly and testing services to AOS. The JV Company reimbursed AOS for purchases made on its behalf of $0.1 million and $2.2 million for the three months ended September 30, 2025 and 2024, respectively.  The purchases by AOS for the three months ended September 30, 2025 and 2024 were $30.4 million and $28.3 million, respectively.  Due to the right of offset of receivables and payables with the JV Company, as of September 30, 2025 and June 30, 2025, AOS recorded the net amount of $21.2 million and $15.8 million, respectively, as a payable related to equity investee, net, on the Condensed Consolidated Balance Sheet.  During the three months ended September 30, 2025, the Company also recorded approximately $1.9 million other income for certain service the Company provided to the JV Company.

9

ALPHA AND OMEGA SEMICONDUCTOR LIMITEDNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

4. Net Loss Per Common Share 

The following table presents the calculation of basic and diluted net loss per share attributable to common shareholders: Three Months Ended September 30, 20252024(in thousands, except per share data)Numerator:Net loss$(2,122)$(2,496)Denominator:Basic:Weighted average number of common shares used to compute basic net loss per share30,036 29,004 Diluted:Weighted average number of common shares used to compute diluted net loss per share30,036 29,004 Net loss per common share:Basic$(0.07)$(0.09)Diluted$(0.07)$(0.09)The following potential dilutive securities were excluded from the computation of diluted net loss per common share as their effect would have been anti-dilutive: Three Months Ended September 30, 20252024(in thousands)Employee stock options and RSUs2,420 2,583 ESPP327 704 Total potential dilutive securities